Nothing Special   »   [go: up one dir, main page]

Ziacchi et al., 2019 - Google Patents

Bipolar active fixation left ventricular lead or quadripolar passive fixation lead? An Italian multicenter experience

Ziacchi et al., 2019

Document ID
1276793670430656430
Author
Ziacchi M
Giannola G
Lunati M
Infusino T
Luzzi G
Rordorf R
Pecora D
Bongiorni M
De Ruvo E
Biffi M
Publication year
Publication venue
Journal of Cardiovascular Medicine

External Links

Snippet

Aims About one-third of patients receiving cardiac resynchronization therapy (CRT) are not responders, due to either patient selection or technical issues. Left ventricular quadripolar passive fixation leads (QPL) and bipolar active fixation (BAF) leads have been designed to …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium, e.g. biventricular stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056—Transvascular endocardial electrode systems
    • A61N1/057—Anchoring means; Means for fixing the head inside the heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39—Heart defibrillators
    • A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body

Similar Documents

Publication Publication Date Title
Keene et al. His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: insights from a large international observational study
Forleo et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study
Migliore et al. Intermuscular two‐incision technique for subcutaneous implantable cardioverter defibrillator implantation: results from a multicenter registry
Burke et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry
Gras et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety
Ziacchi et al. Bipolar active fixation left ventricular lead or quadripolar passive fixation lead? An Italian multicenter experience
Biffi et al. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site
Barba-Pichardo et al. Permanent His-bundle pacing: seeking physiological ventricular pacing
Forleo et al. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes
Rusanov et al. A 15-year experience with permanent pacemaker and defibrillator lead and patch extractions
Sharma et al. Conduction system pacing for cardiac resynchronisation
Sharma et al. Permanent His bundle pacing: the past, present, and future
Shetty et al. Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy
Bernard Pacing without wires: leadless cardiac pacing
Biffi et al. Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?
De Leon et al. Adopting permanent His bundle pacing: learning curves and medium-term outcomes
Thompson et al. The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest
Kolb et al. Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients—Results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study
Ohlow et al. The use of a quadripolar left ventricular lead increases successful implantation rates in patients with phrenic nerve stimulation and/or high pacing thresholds undergoing cardiac resynchronisation therapy with conventional bipolar leads
Rademakers et al. Left bundle branch pacing as an alternative to biventricular pacing for cardiac resynchronisation therapy
Chinyere et al. The emerging role of cardiac contractility modulation in heart failure treatment
Zingarini et al. Permanent His bundle pacing using a new tridimensional delivery sheath and a standard active fixation pacing lead: The telescopic technique
Lopez Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery
Yu et al. Learning Curve Analyses for Left Bundle Branch Area Pacing with Conventional Stylet‐Driven Pacing Leads
Lewis et al. Clinical experience with subcutaneous implantable cardioverter-defibrillators